Literature DB >> 26228164

Course of symptom change during anxiety treatment: Reductions in anxiety and depression in patients completing the Coordinated Anxiety Learning and Management program.

Jessica Bomyea1, Ariel Lang2, Michelle G Craske3, Denise A Chavira3, Cathy D Sherbourne4, Raphael D Rose3, Daniela Golinelli4, Laura Campbell-Sills5, Stacy S Welch6, Greer Sullivan7, Alexander Bystritsky8, Peter Roy-Byrne6, Murray B Stein9.   

Abstract

When treating anxious patients with co-occurring depression, research demonstrates that both types of symptoms independently improve. The current analyses examined how reductions in anxiety and depression may be interrelated both during treatment, as well as over time following treatment. Participants were 503 individuals with one or more DSM-IV anxiety disorders who completed a collaborative care anxiety management program. Anxiety and depression were assessed at each treatment session (i.e., session by session data) and also at 6, 12, and 18-month post-baseline assessments (i.e., long-term outcomes data). Mediation analyses examined changes in symptoms in session by session data and long-term outcomes data. Anxiety and depression changed reciprocally in session by session data; change in anxiety mediated change in depression to a greater extent than vice versa. In the long-term outcomes data, change in anxiety mediated change in depression. However, the reverse mediation model of the long-term outcomes period revealed that accounting for changes in depression altered the effect of time on anxiety. Thus, temporal change during active treatment may share similarities with those related to maintaining gains after treatment, although differences arose in the reverse mediation models. Limitations of the methodology and implications of anxiety treatment for depression outcomes are discussed.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety; CBT; Depression; Mediation; Treatment

Mesh:

Year:  2015        PMID: 26228164      PMCID: PMC4656042          DOI: 10.1016/j.psychres.2015.07.056

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  42 in total

1.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

2.  Mediation analysis.

Authors:  David P MacKinnon; Amanda J Fairchild; Matthew S Fritz
Journal:  Annu Rev Psychol       Date:  2007       Impact factor: 24.137

3.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

4.  Training primary care staff to deliver a computer-assisted cognitive-behavioral therapy program for anxiety disorders.

Authors:  Raphael D Rose; Ariel J Lang; Stacy Shaw Welch; Laura Campbell-Sills; Denise A Chavira; Greer Sullivan; Cathy Sherbourne; Alexander Bystritsky; Murray B Stein; Peter P Roy-Byrne; Michelle G Craske
Journal:  Gen Hosp Psychiatry       Date:  2011-06-08       Impact factor: 3.238

5.  Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample.

Authors:  T A Brown; L A Campbell; C L Lehman; J R Grisham; R B Mancill
Journal:  J Abnorm Psychol       Date:  2001-11

6.  Quality-of-life impairment in depressive and anxiety disorders.

Authors:  Mark Hyman Rapaport; Cathryn Clary; Rana Fayyad; Jean Endicott
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

7.  Computer-assisted delivery of cognitive behavioral therapy for anxiety disorders in primary-care settings.

Authors:  Michelle G Craske; Raphael D Rose; Ariel Lang; Stacy Shaw Welch; Laura Campbell-Sills; Greer Sullivan; Cathy Sherbourne; Alexander Bystritsky; Murray B Stein; Peter P Roy-Byrne
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

8.  Validation of a brief measure of anxiety-related severity and impairment: the Overall Anxiety Severity and Impairment Scale (OASIS).

Authors:  Laura Campbell-Sills; Sonya B Norman; Michelle G Craske; Greer Sullivan; Ariel J Lang; Denise A Chavira; Alexander Bystritsky; Cathy Sherbourne; Peter Roy-Byrne; Murray B Stein
Journal:  J Affect Disord       Date:  2008-05-16       Impact factor: 4.839

9.  Temporal course and structural relationships among dimensions of temperament and DSM-IV anxiety and mood disorder constructs.

Authors:  Timothy A Brown
Journal:  J Abnorm Psychol       Date:  2007-05

Review 10.  Quality of life in the anxiety disorders: a meta-analytic review.

Authors:  Bunmi O Olatunji; Josh M Cisler; David F Tolin
Journal:  Clin Psychol Rev       Date:  2007-02-07
View more
  2 in total

1.  Relationships of Depression, Anxiety, and Stress with Adherence to Self-Management Behaviors and Diabetes Measures in African American Adults with Type 2 Diabetes.

Authors:  Diane Orr Chlebowy; Catherine Batscha; Nancy Kubiak; Timothy Crawford
Journal:  J Racial Ethn Health Disparities       Date:  2018-05-29

2.  Cognitive behaviour treatment of co-occurring depression and generalised anxiety in routine clinical practice.

Authors:  Roz Shafran; Abigail Wroe; Sasha Nagra; Eleni Pissaridou; Anna Coughtrey
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.